Cargando…
TxA(2) Receptor‐Based Vaccination: A Novel Potential Therapeutic Approach to Limit Thrombosis
Autor principal: | Ahmad, Firdos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064917/ https://www.ncbi.nlm.nih.gov/pubmed/29936415 http://dx.doi.org/10.1161/JAHA.118.009861 |
Ejemplares similares
-
Role of Prednisolone in Platelet Activation by Inhibiting TxA(2) Generation through the Regulation of cPLA(2) Phosphorylation
por: Kim, Sanggu, et al.
Publicado: (2023) -
Multi-omics study of silicosis reveals the potential therapeutic targets PGD(2) and TXA(2)
por: Pang, Junling, et al.
Publicado: (2021) -
Study conclude that TXA in severely injured was associated with lower mortality: beware of potential confounders
por: Honore, Patrick M., et al.
Publicado: (2021) -
TXA (Tranexamic Acid) Risk Evaluation in Combat Casualties (TRECC)
por: Adair, Kathleen E, et al.
Publicado: (2020) -
Genetic variants of PTGS2, TXA2R and TXAS1 are associated with carotid plaque vulnerability, platelet activation and TXA2 levels in ischemic stroke patients
por: Yi, Xingyang, et al.
Publicado: (2017)